Patricia Aguilar-Martinez Selected Research

Thrombosis (Thrombus)

1/2019

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Aguilar-Martinez Research Topics

Disease

7	Iron Overload 01/2022 - 10/2004
6	Hemochromatosis (Bronze Diabetes) 01/2016 - 11/2003
4	Anemia 11/2022 - 11/2011
3	Hyperferritinemia 01/2019 - 05/2005
2	Hemorrhage 04/2024 - 04/2002
2	Hypoxia (Hypoxemia) 12/2022 - 02/2017
2	Polycythemia (Erythrocytosis) 12/2022 - 02/2017
2	hereditary Xerocytosis 01/2019 - 10/2018
2	Hemolysis 01/2019 - 10/2018
2	Hemolytic Anemia 02/2017 - 11/2011
2	hereditary Hyperferritinemia with congenital cataracts 04/2013 - 05/2005
2	Porphyria Cutanea Tarda 01/2011 - 01/2004
2	beta-Thalassemia (Cooley's Anemia) 07/2010 - 12/2007
2	type 2 Hemochromatosis 12/2007 - 09/2007
1	Hypertension (High Blood Pressure) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Pancytopenia 01/2020
1	Channelopathies 01/2019
1	Edema (Dropsy) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Inflammation (Inflammations) 02/2017
1	Neoplasms (Cancer) 02/2017
1	Iron-Refractory Iron Deficiency Anemia 09/2012
1	Movement Disorders (Movement Disorder) 11/2011
1	Neurologic Manifestations (Neurological Manifestations) 11/2011
1	Intellectual Disability (Idiocy) 11/2011
1	Seizures (Absence Seizure) 11/2011
1	Pseudohyperkalemia Cardiff 11/2011
1	Cataract (Cataracts) 11/2011
1	Hemoglobinopathies 07/2010
1	type 4 Hemochromatosis 09/2007
1	Factor VII Deficiency (Hypoproconvertinemia) 02/2003
1	Epistaxis (Nosebleed) 04/2002
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 03/2002

Drug/Important Bio-Agent (IBA)

7	IronIBA 01/2022 - 10/2004
6	HepcidinsIBA 02/2017 - 10/2004
4	metal transporting protein 1 (ferroportin)IBA 01/2022 - 05/2005
4	Transferrin (beta 2 Transferrin)IBA 01/2016 - 09/2007
3	Hemoglobins (Hemoglobin)IBA 12/2022 - 02/2017
3	Ferritins (Ferritin)IBA 01/2022 - 11/2003
3	Transferrin Receptors (Transferrin Receptor)IBA 07/2013 - 09/2007
2	beta-Globins (beta Globin)IBA 12/2022 - 12/2007
2	Oxygen (Dioxygen)IBA 12/2022 - 02/2017
2	Peptides (Polypeptides)IBA 02/2017 - 12/2007
2	ApoferritinsIBA 04/2013 - 05/2005
2	5' Untranslated Regions (5' UTR)IBA 04/2013 - 12/2007
2	CationsIBA 11/2011 - 07/2010
2	factor VII clotting antigenIBA 04/2002 - 03/2002
1	Thrombin FDA Link 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2022
1	hemoglobin AgrinioIBA 11/2022
1	Dietary IronIBA 01/2016
1	LigandsIBA 01/2016
1	Bone Morphogenetic Protein 6IBA 01/2016
1	matriptase 2IBA 09/2012
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2011
1	Monovalent CationsIBA 11/2011
1	Antimicrobial PeptidesIBA 12/2007
1	Ceruloplasmin (Ferroxidase)IBA 05/2005
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2004
1	Nonsense Codon (Nonsense Mutation)IBA 02/2003
1	Factor VII (Proconvertin)IBA 04/2002

Therapy/Procedure

2	Therapeutics 11/2003 - 04/2002
1	Blood Transfusion (Blood Transfusions) 01/2020
1	Splenectomy 01/2019
1	Minor Surgical Procedures (Minor Surgery) 04/2002